(AB, RF,VA, CB,VV, JMA) binding, whereas histamine and tele-methylhistamine had no effect. In conclusion, the histamine-induced potentiation of NMDARs occurs in the brain under normal conditions.
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INTRODUCTION
Histamine neurons constitute a long and highly divergent system arising from the tuberomammillary nucleus in the posterior hypothalamus and projecting in a diffuse manner to many cerebral areas. The function of these neurons in the modulation of physiological processes such as arousal or cognitive functions is well documented, but their involvement in brain disorders remains poorly understood. In the brain, the effects of histamine are mediated by three histamine receptor subtypes (H 1 , H 2 and H 3 ), which are all G protein coupled receptors. Brain histamine is metabolized via transmethylation into tele-methylhistamine (tele-MeHA) catalyzed by histamine N-methyltransferase, and this metabolite is devoid of any activity at histamine receptors (Brown et al., 2001 ).
More than fifteen years ago, histamine has been reported to act as a positive allosteric modulator of the N-methyl-D-aspartate receptor (NMDAR). Histamine potentiated NMDA currents in isolated (Vorobjev et al., 1993) , and cultured (Bekkers, 1993) hippocampal neurons. Its effect resulted from a direct interaction with the NMDAR, the potentiation being observed on recombinant NMDARs. Moreover, it was selective for receptors containing NR1 variants lacking exon 5 with NR2B subunits (Williams, 1994b; Williams, 1995) .
However, in spite of the potential therapeutic interest of allosteric modulators of the NMDAR for the treatment of various neurological or psychiatric disorders (Paoletti and Neyton, 2007) , very few studies have been performed on this histamine-induced potentiation.
One probable explanation for this rather limited interest is that its physiological relevance has remained unclear. Indeed, at the physiological pH of 7.4, histamine failed to potentiate the NMDA component of EPSCs in rat and mouse hippocampal slices (Saybasili et al., 1995; Yanovsky et al., 1995; Bekkers et al., 1996) . Although poorly characterized, some other responses could however reflect an interaction of histamine with NMDARs. Among them, histamine facilitated the NMDA-induced depolarization of projection neurons in cortical This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on December 15, 2009 as DOI: 10.1124 at ASPET Journals on November 7, 2016 jpet.aspetjournals.org Downloaded from slices (Payne and Neuman, 1997) . Phase shifts of the circadian clock induced by histamine in slices of the hamster suprachiasmatic nucleus were NMDA dependent (Meyer et al., 1998) .
Histamine might also act through NMDARs to facilitate the induction of long-term potentiation (Brown et al., 1995) , and to cause long-lasting increases of excitability (Selbach et al., 1997) in the CA1 region of rat hippocampal slices. In vivo, histamine reversed spatial memory deficits induced in rats by the NMDAR glycine site antagonist 7-chlorokynurenic acid (Nishiga and Kamei, 2003) , and facilitated a NMDA-dependent long-term potentiation in the visual cortex (Kuo and Dringenberg, 2008) .
Another explanation for the limited interest in the histamine-induced potentiation likely results from the fact that histamine was generally thought, not to interact with a selective site, but with the polyamine allosteric site of the NMDAR (Brown et al., 2001 ).
Histamine-and spermine-induced potentiations shared many similarities, including NR2B selectivity (Williams, 1994b; Williams et al., 1994; Williams, 1995) , pH-dependence (Saybasili et al., 1995; Traynelis et al., 1995; Yanovsky et al., 1995) , and voltageindependence (Vorobjev et al., 1993; Williams, 1994b; Williams, 1994a) . In other studies, the effect of histamine was occluded by spermine (Vorobjev et al., 1993) , or inhibited by the polyamine antagonist arcaine (Kuo and Dringenberg, 2008; Watanabe et al., 2008) . However, in all these models, histamine and spermine were both active, and whether they bound to a common site, or to separate sites with allosteric interactions, remained unclear.
In this study, we further investigated and characterized the histamine-mediated potentiation of native NMDARs by using four different models: NMDAR-mediated currents and intracellular calcium in single cultured neurons, NMDA-mediated 
METHODS
Primary neuronal cultures.
The hippocampus was removed from 18-day-old embryos of male Wistar rats (Janvier, Le
Genest-St-Isle, France). Cells were dissociated with a fire-narrowed Pasteur pipette and were seeded on 12-well culture dishes (100, 000 cells/well containing 1 ml of medium), previously coated with poly D-lysine. When intracellular Ca 2+ was measured, cells were plated on glass slides previously coated with poly L-ornithine (15 µg/ml) and laminin (2 µg/ml) at a seeding density of 1 million cells/ml.
After removal of the coating solution, cells were seeded in neurobasal medium supplemented with B27 (1:50), GlutaMAX-I-(2 mM) and penicillin-streptomycin (5 IU/ml and 5 µg/ml, respectively). In these conditions, cultures of neurons were favoured at the expense of glial cells. Neurons were maintained for 2 to 4 weeks at 37°C in a humidified atmosphere containing 5% CO2. For intracellular Ca 2+ measurement, neurons were maintained for 7 to 11 days in vitro (DIV) without medium change.
Whole-cell patch clamp.
Ionic currents were recorded within large pyramidal neurons using the whole-cell patch clamp technique at room temperature (21-22 C). Pipette electrodes were made from 1.5 mm (outer diameter) borosilicate glass tubes with a resistance of 2 to 3 M when filled with the internal solution. The membrane potential was clamped at -50 mV. The whole-cell current recording started 5 to 10 min after membrane rupture in order that the cell interior adequately equilibrates with the pipette solution. Currents through the electrode were recorded with an Axopatch-1D amplifier (Axon Instruments, Union City, CA), filtered at 2 kHz, and sampled at 10 kHz in a PC-based data acquisition system that also provided preliminary data analysis.
This article has not been copyedited and formatted. The final version may differ from this version. A crude synaptosomal fraction was prepared as previously described with minor modifications (Gray and Whittaker, 1962 µM Fura-2F AM. After loading, the glass slide was placed in a perfusion chamber where cells were exposed to buffer (20 mM HEPES, 140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1.2 mM MgCl 2 , glucose 1g/l). When required, neurons were exposed to tested compounds in the same buffer in which Mg 2+ was omitted (Mg 2+ free buffer) using a multichannel superfusion device.
Neurons were alternatively excited at 340-380 nm using a Hamamatsu monochromator.
Emission intensities were monitored at 510 nm. The camera dark noise was subtracted from the recorded crude image (camera and digitizing system were from Hamamatsu, Hamamatsu, A glycine concentration as low as 10 nM being able to activate NMDA currents and being found in purified water and reagents (Ascher, 1990; Pittaluga and Raiteri, 1990) , we used such a perfusion system in order to remove the endogenous glycine and D-serine present in the medium.
Analysis of Data.
The total curves were analyzed with an iterative least-squares method derived from that of Parker and Waud (Parker and Waud, 1971 Histamine (HA, 50 µM) added alone had no effect (data not shown), but increased NMDA currents generated by L-aspartate or NMDA (50 µM) in hippocampal neurons ( Figure   1A ). Its effect considerably varied between neurons and 6 out of 21 (about 30 % of the total)
did not respond to histamine. After analysis of the remaining 15 responsive neurons on three different parameters, histamine induced a mean potentiation of 20 12 % of the relative current, of 22 9 % of the peak of the current, and of 15 13 % of the following plateau. The potentiation of the relative current varied from 9% up to 47% for the highest responses such as that shown in Figure 1A .
tele-Methylhistamine (tele-MeHA, 50 µM) added alone had no effect but potentiated also NMDA currents with an effect very similar to that of histamine. It increased by 26 13 % the relative current (values ranging from 8% to 44%), by 25 10 % the peak of the current, and by 17 15 % the plateau (n = 7 cells) ( Figure 1A ). Again, three neurons did not respond to tele-methylhistamine.
Histamine and tele-methylhistamine increased in a concentration-dependent manner the relative current with EC 50 values of 8.8 ± 2.1 µM and 7.2 ± 1.5 µM, respectively ( Figure   1B ). NMDA was concentration-dependent with an EC 50 value of 8.2 ± 2.8 µM and a maximal effect of 7,800 ± 1,100 dpm/mg of protein. The releasing effect of NMDA (200µM) in hippocampal synaptosomes was differentially modulated by various histaminergic derivatives used ( Figure 3A and Table 1) .
Characterisation of [
When tested at 100 µM, histamine and tele-methylhistamine increased by fourfold the effect µM tended to enhance [ 3 H]noradrenaline release, its effect becoming significant at higher concentrations ( Figure 3A and Table 1 ). Figure 3B ). MK-801 and the selective NR2B antagonist ifenprodil inhibited in a concentration-dependent manner the effect of tele-methylhistamine (100 µM) with a maximal inhibition of~80% and IC 50 values of 0.27 ± 0.17 µM and 0.14 ± 0.04 µM, respectively ( Figure 3C ). The preferential NR2A antagonist PEAQX (1 µM) (Auberson et al., 2002) had no significant effect (-8 +/-11 %). The increase induced by tele-methylhistamine was partially decreased by the H 3 -receptor agonist imetit at 100µM. It was also fully antagonised by impromidine, an antagonist of histamine on NMDA currents (Bekkers, 1993) , with an IC 50 value of 15 ± 3 µM ( Figure 3C and Table 1 ). In contrast, it was not modified by 100µM bicuculline, a GABA A receptor competitive antagonist ( Figure 3C ).
The preferential H 1 -receptor agonist 2-pyridylethylamine (PEA) (EC 50 of 5.0 ± 0.5 µM) and 4-methylimidazole (EC 50 of 50 ± 28 µM) induced a maximal increase of release and therefore behaved as full agonists. ( R ) α -methylhistamine (EC 50 of 41 ± 24 µM) and the H 2 /H 3 -receptor antagonist burimamide (EC 50 of 6 ± 2 µM) behaved as apparent partial agonists, compared to histamine and tele-methylhistamine ( Figure 4A and Table 1 ). The increase induced by PEA (100 µM) was inhibited in a concentration-dependent manner by ifenprodil and impromidine ( Figure 4B ). Impromidine alone also decreased NMDA-induced release (data not shown).
Histamine and tele-methylhistamine also enhanced The effects of spermine and histamine were first compared on the non-equilibrium Analysis of its inhibition curve by nonlinear regression led to a mean IC 50 value of 8.9 2.5 µM with a pseudo-Hill coefficient of 0.7 0.1. This inhibition by ifenprodil remained unchanged in the presence of 100 µM histamine (n H = 0.7 0.1; mean IC 50 = 9.2 2.5 µM ( Figure 7C ).
In kinetic studies, the slow kinetics of association of Figure 9A ). In the presence of 30 µM glycine, spermine still induced a significant increase (+126 13%, p< 0.01), whereas the increase induced by tele-methylhistamine (+28 10%) became non significant ( Figure 9B ).
Spermine (10 µM) completely inhibited [ 3 H]ifenprodil binding to hippocampal membranes, whereas histamine (100 µM and 1 mM) had no effect (Figure 10 ). 
Effect of histamine on NMDA-induced increase in intracellular Ca
DISCUSSION
This study shows that histamine potentiates NR2B-containing NMDARs in the brain by interacting with a functional site distinct from the polyamine site. The potentiation by histamine was previously observed in neurons, but not in complex models such as slices (Bekkers, 1993; Bekkers et al., 1996) . Whatever the mechanisms underlying these differences, histamine could potentiate NMDA not only in neurons, but also in synaptosomes, a preparation enriched in nerve endings. NMDA. This is likely due to their slow association kinetics, together with the short incubation used in our assay.
The histamine-induced enhancement of NMDA currents remained poorly characterized because most compounds had been tested at one concentration only (Bekkers, 1993; Vorobjev et al., 1993; Williams, 1994b) . However, two striking features were observed, i.e. the enhancement reproduced by tele-methylhistamine, the catabolite of histamine in the brain, and the antagonism of histamine by the H 2 agonist/H 3 antagonist impromidine (Bekkers, 1993; Williams, 1994b) . We show that histamine and tele-methylhistamine are equipotent on NMDA currents. Their effects are selective of NMDARs, being found with Laspartate or NMDA, but not with quisqualate or kainate (Vorobjev et al., 1993) .
Compared to patch-clamp, the release model was more suitable for a proper characterization of the response because concentration-response curves could be more easily (Williams, 1994b; Williams, 1995) , the release of
]noradrenaline evoked by tele-methylhistamine was antagonized by the NR2B antagonist ifenprodil (Williams, 1993; Avenet et al., 1997) , but not by PEAQX used at a concentration
(1 µM) known to block only NR2A-containg receptors (Auberson et al., 2002) . Thirdly, impromidine antagonized tele-methylhistamine (Table 1) , and reduced NMDA-induced currents (Bekkers, 1993) and [ 3 H]noradrenaline release, indicating that it acted in fact as an inverse agonist. Lastly, both currents (Bekkers, 1993; Williams, 1994b) (Smits et al., 1988) . Also, histamine did not inhibit [ 3 H]noradrenaline uptake in synaptosomes at concentrations up to 1 mM (Tuomisto and Tuomisto, 1980 In patch-clamp studies, the EC 50 of histamine (~10 µM) as an enhancer of NMDA currents was similar to that reported (Vorobjev et al., 1993; Williams, 1994b) . However, histamine was tenfold less potent in synaptosomes (EC 50 = 99 ± 17µM, Table 1 ), which may result from differences between presynaptic adult vs postsynaptic embryonic NMDARs.
Moreover, as shown (Vorobjev et al., 1993; Zwart et al., 1996; Meyer et al., 1998) because a large increase (by up to tenfold) was also observed on NMDA-mediated synaptic transmission (Bekkers, 1993) .
Histamine and tele-methylhistamine alone had no effect on intracellular Ca 2+ or NMDA currents. However, they still enhanced [ 3 H]noradrenaline release in the absence of NMDA. Their effect was again suppressed by MK-801, ifenprodil and impromidine, confirming an interaction with NMDARs. Activation of NMDARs by endogenous glutamate was excluded, because NMDAR antagonists did not decrease basal release. Moreover, histamine had no effect with low concentrations of glutamate (Vorobjev et al., 1993; Williams, 1994b Up to now, histamine was considered to interact with the polyamine site of the NMDAR (Brown et al., 2001 ). However, already suggesting that histamine and spermine might bind to separate sites, histamine, but not spermine, produced a desensitization of recombinant NMDARs (Williams, 1994b) . In fact, the effects of histamine and spermine were clearly discriminated in our models. As reported (Woodward and Cueto, 1993 binding (Ransom and Stec, 1988; Williams et al., 1989) , whereas histamine and telemethylhistamine induced no effect, except an inhibition at high concentrations. Spermine totally inhibited [ 3 H]ifenprodil binding, whereas histamine had again no effect on this binding.
The increase in binding induced by spermine was attenuated by histamine at a concentration without any effect alone. This modulation of spermine effects by histamine, as well as the modulation of histamine effects by polyamines in other systems (Vorobjev et al., 1993; Kuo and Dringenberg, 2008; Watanabe et al., 2008) , strongly suggest the existence of allosteric interactions between the histamine and polyamine sites. These observations are reminiscent of those previously made for ifenprodil and polyamine sites. Although they were originally thought to bind at the same site, ifenprodil and polyamines bind in fact to separate sites with allosteric interactions (Kew and Kemp, 1998; Han et al., 2008) . Ifenprodil antagonized tele-methylhistamine on [ 3 H]noradrenaline release, and decreased histaminemediated nociception (Watanabe et al., 2008) . However, histamine and ifenprodil do not bind at a common site since histamine failed to displace Therefore, histamine does not bind to the polyamine and ifenprodil sites, but interacts with a distinct histamine site (NMDA (HA) R). The molecular mechanisms, by which histamine potentiates NMDA, remain unknown and will be better addressed with more potent compounds. The moderate increase of [ 3 H]CGP39653 binding, a radioligand of the glutamate site, induced by tele-methylhistamine, might suggest allosteric interactions between the histamine and glutamate sites. The saturating glycine concentration used in patch-clamp confirms a glycine-independent effect of histamine (Bekkers, 1993; Vorobjev et al., 1993; Williams, 1994b; Zwart et al., 1996) . In addition, histamine potentiated increases in calcium in the presence of a saturating D-serine concentration. In the release model, the presence of endogenous glycine made it impossible to study adequately the glycine-dependence of the (NMDA (HA) R). In superfused neurons, the NMDA-induced increase in intracellular calcium strongly suggested that histamine has also a glycine-dependent effect. In the absence of Dserine, NMDA alone had no effect, but histamine and NMDA increased calcium concentrations, suggesting that histamine increased the affinity of the receptor for glycine.
Due to perfusion, contaminant glycine is not present at high enough concentrations to serve as co-agonist without histamine, but may become active, when its affinity for the glycine site is increased by histamine. Supporting our data, the potentiation of NMDA currents by histamine was higher at 0.1 µM than at 10 µM glycine, not only in neurons (Vorobjev et al., 1993) but also in transfected oocytes (Williams, 1994b) , and on [ 3 H]CGP39653 binding, the effect of tele-methylhistamine became non significant with glycine.
The positive effect of its metabolite in the brain suggests that histamine may not be the primary agonist of the NMDA (HA) R. However, our in vitro data show that histamine does potentiate NMDARs in the brain at concentrations (10-100µM) similar to those activating H 1 and H 2 receptors in brain (Brown et al., 2001) . Therefore, both endogenous histamine and tele-methylhistamine may reach high enough concentrations to activate NMDARs in vivo, at 
